vs
Side-by-side financial comparison of Arena Group Holdings, Inc. (AREN) and LIFECORE BIOMEDICAL, INC. \DE\ (LFCR). Click either name above to swap in a different company.
LIFECORE BIOMEDICAL, INC. \DE\ is the larger business by last-quarter revenue ($31.1M vs $28.2M, roughly 1.1× Arena Group Holdings, Inc.). Arena Group Holdings, Inc. runs the higher net margin — 18.9% vs -32.1%, a 51.0% gap on every dollar of revenue. On growth, LIFECORE BIOMEDICAL, INC. \DE\ posted the faster year-over-year revenue change (-4.5% vs -22.0%). Over the past eight quarters, LIFECORE BIOMEDICAL, INC. \DE\'s revenue compounded faster (-0.1% CAGR vs -1.2%).
Arena Racing Company, also called ARC Racing and Leisure Group is a UK private company, created in 2012 by the merger of Arena Leisure and Northern Racing. It owns and operates 16 racecourses in Great Britain, accounting for 39% of British racing fixtures. It also operates hotels at Wolverhampton Racecourse, Lingfield Park Racecourse and Doncaster Racecourse and golf courses at Lingfield, Southwell and Newcastle.
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
AREN vs LFCR — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $28.2M | $31.1M |
| Net Profit | $5.3M | $-10.0M |
| Gross Margin | 43.6% | 25.0% |
| Operating Margin | 26.6% | -9.9% |
| Net Margin | 18.9% | -32.1% |
| Revenue YoY | -22.0% | -4.5% |
| Net Profit YoY | -22.5% | -52.0% |
| EPS (diluted) | $0.12 | $-0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $28.2M | — | ||
| Q3 25 | $29.8M | $31.1M | ||
| Q2 25 | $45.0M | — | ||
| Q1 25 | $31.8M | $35.2M | ||
| Q4 24 | $36.2M | $32.6M | ||
| Q3 24 | $33.6M | $24.7M | ||
| Q2 24 | $27.2M | — | ||
| Q1 24 | $28.9M | $35.7M |
| Q4 25 | $5.3M | — | ||
| Q3 25 | $6.9M | $-10.0M | ||
| Q2 25 | $108.6M | — | ||
| Q1 25 | $4.0M | $-14.8M | ||
| Q4 24 | $6.9M | $-6.6M | ||
| Q3 24 | $4.0M | $-16.2M | ||
| Q2 24 | $-8.2M | — | ||
| Q1 24 | $-103.4M | $15.6M |
| Q4 25 | 43.6% | — | ||
| Q3 25 | 50.2% | 25.0% | ||
| Q2 25 | 56.5% | — | ||
| Q1 25 | 49.3% | 28.0% | ||
| Q4 24 | 52.6% | 34.0% | ||
| Q3 24 | 50.6% | 21.8% | ||
| Q2 24 | 39.4% | — | ||
| Q1 24 | 30.9% | 33.3% |
| Q4 25 | 26.6% | — | ||
| Q3 25 | 31.9% | -9.9% | ||
| Q2 25 | 36.5% | — | ||
| Q1 25 | 23.1% | -25.7% | ||
| Q4 24 | 28.6% | -6.0% | ||
| Q3 24 | 24.0% | -46.9% | ||
| Q2 24 | -9.5% | — | ||
| Q1 24 | -27.5% | -2.5% |
| Q4 25 | 18.9% | — | ||
| Q3 25 | 23.1% | -32.1% | ||
| Q2 25 | 241.4% | — | ||
| Q1 25 | 12.6% | -42.0% | ||
| Q4 24 | 19.0% | -20.2% | ||
| Q3 24 | 11.8% | -65.7% | ||
| Q2 24 | -30.1% | — | ||
| Q1 24 | -357.1% | 43.8% |
| Q4 25 | $0.12 | — | ||
| Q3 25 | $0.14 | $-0.29 | ||
| Q2 25 | $2.28 | — | ||
| Q1 25 | $0.08 | $-0.47 | ||
| Q4 24 | $1.23 | $-0.25 | ||
| Q3 24 | $0.11 | $-0.53 | ||
| Q2 24 | $-0.28 | — | ||
| Q1 24 | $-3.91 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $10.3M | $18.9M |
| Total DebtLower is stronger | $97.6M | $136.0M |
| Stockholders' EquityBook value | $-4.8M | $-10.5M |
| Total Assets | $112.6M | $235.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $10.3M | — | ||
| Q3 25 | $12.5M | $18.9M | ||
| Q2 25 | $6.8M | — | ||
| Q1 25 | $2.9M | $5.4M | ||
| Q4 24 | $4.4M | $9.5M | ||
| Q3 24 | $5.8M | — | ||
| Q2 24 | $6.1M | — | ||
| Q1 24 | $4.0M | — |
| Q4 25 | $97.6M | — | ||
| Q3 25 | $110.5M | $136.0M | ||
| Q2 25 | $110.5M | — | ||
| Q1 25 | $110.5M | $124.9M | ||
| Q4 24 | $110.4M | $111.3M | ||
| Q3 24 | $102.4M | $106.3M | ||
| Q2 24 | $102.4M | — | ||
| Q1 24 | $102.3M | $97.1M |
| Q4 25 | $-4.8M | — | ||
| Q3 25 | $-10.4M | $-10.5M | ||
| Q2 25 | $-17.3M | — | ||
| Q1 25 | $-126.1M | $2.2M | ||
| Q4 24 | $-130.3M | $15.4M | ||
| Q3 24 | $-137.5M | $-3.9M | ||
| Q2 24 | $-157.2M | — | ||
| Q1 24 | $-149.6M | $17.7M |
| Q4 25 | $112.6M | — | ||
| Q3 25 | $121.4M | $235.2M | ||
| Q2 25 | $127.8M | — | ||
| Q1 25 | $114.6M | $237.7M | ||
| Q4 24 | $116.4M | $255.4M | ||
| Q3 24 | $114.2M | $246.8M | ||
| Q2 24 | $113.4M | — | ||
| Q1 24 | $120.3M | $246.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 56.05× | ||
| Q4 24 | — | 7.20× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 5.49× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $13.1M | $1.8M |
| Free Cash FlowOCF − Capex | — | $25.0K |
| FCF MarginFCF / Revenue | — | 0.1% |
| Capex IntensityCapex / Revenue | — | 5.6% |
| Cash ConversionOCF / Net Profit | 2.46× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-16.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $13.1M | — | ||
| Q3 25 | $12.2M | $1.8M | ||
| Q2 25 | $10.3M | — | ||
| Q1 25 | $3.7M | $1.2M | ||
| Q4 24 | $-8.6M | $-6.1M | ||
| Q3 24 | $-2.3M | $-613.0K | ||
| Q2 24 | $-3.2M | — | ||
| Q1 24 | $-2.0M | $-1.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | $25.0K | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $-4.3M | ||
| Q4 24 | — | $-8.6M | ||
| Q3 24 | $-2.4M | $-4.0M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $-7.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -12.1% | ||
| Q4 24 | — | -26.3% | ||
| Q3 24 | -7.1% | -16.3% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -21.8% |
| Q4 25 | — | — | ||
| Q3 25 | 0.0% | 5.6% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 15.5% | ||
| Q4 24 | — | 7.5% | ||
| Q3 24 | 0.1% | 13.9% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 17.8% |
| Q4 25 | 2.46× | — | ||
| Q3 25 | 1.77× | — | ||
| Q2 25 | 0.09× | — | ||
| Q1 25 | 0.91× | — | ||
| Q4 24 | -1.25× | — | ||
| Q3 24 | -0.59× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -0.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AREN
Segment breakdown not available.
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
